Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Busy address KBO
10 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
LABO VOOR KLINISCHE BIOLOGIE from Evergem, company number BE0451023967, closed financial year 2025 with a result of € 417,943 after tax. For that financial year LABO VOOR KLINISCHE BIOLOGIE recorded a gross margin of € 3.6 million and equity of € 8.6 million. Compared with financial year 2024, the result moved from € 1.3 million to € 417,943. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
€ 8.6 million
▲ 5% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 417,943
▼ 69% vs 2024
Profit after tax over the fiscal year.
€ 87,188
▼ 96% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 8.5 million.
People and assets in 2025
28.6
▲ 1.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 2.1 million
▲ 6% vs 2024
€ 72,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 286,101
▼ 17% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 936,029
▲ 177% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 283,486
▼ 35% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 3,730,020 | € 3,222,322 | € 4,629,676 | € 3,553,574 | ▼ 23% |
| Profit after taxes | € 1,063,419 | € 520,281 | € 1,331,286 | € 417,943 | ▼ 69% |
| Equity | € 6,371,995 | € 6,892,276 | € 8,223,562 | € 8,641,505 | ▲ 5% |
| Total debts | € 1,003,416 | € 1,402,505 | € 831,365 | € 1,221,194 | ▲ 47% |
| Cash | € 2,210,110 | € 1,186,315 | € 2,490,258 | € 87,188 | ▼ 96% |
| Land & buildings | € 3,944,842 | € 3,777,905 | € 3,611,103 | € 3,437,229 | ▼ 5% |
| Retained profit | € 6,201,995 | € 6,722,276 | € 8,053,562 | € 8,471,505 | ▲ 5% |
| Balance sheet total | € 7,375,411 | € 8,294,781 | € 9,182,665 | € 9,982,997 | ▲ 9% |
| Employees (FTE) | 29.7 | 28 | 27.2 | 28.6 | ▲ 1.4 |
Key figures of LABO VOOR KLINISCHE BIOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to LABO VOOR KLINISCHE BIOLOGIE?
What happened at LABO VOOR KLINISCHE BIOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 417,943 (▼ 69% vs 2024). Source: NBB ↗
- New establishment in Brugge. KBO
- Emiel Van Camp became a director. NBB
- Post Verba Verbera NV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.1 million profit in 2022 to € 417,943 profit in 2025.
Paid € 1.1 million in corporate taxes since 2022.
Best year ever: 2024, with € 1.3 million profit.
On average € 124,300 of value added per employee in 2025.
A new publication or filing at LABO VOOR KLINISCHE BIOLOGIE? We notify you, reason included.
Follow LABO VOOR KLINISCHE BIOLOGIEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of POST VERBA VERBERA comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LABO VOOR KLINISCHE BIOLOGIEBehind LABO VOOR KLINISCHE BIOLOGIE are Emiel Van Camp and Post Verba Verbera NV. The shares are held by POST VERBA VERBERA (100%).
Directors
According to the 2025 annual accounts
Emiel Van Camp
Director
Also active at: LABORATORIUM M. NUYTINCK, QUOD BONUM, FELIX FAUSTUMQUE SIT, POST VERBA VERBERA, ANABIOTEC, OHMX.bio, ERGO TUA RURA MANEBUNT
since 2018
Director · represented by Margareta Nuytinck
Also active at: LABORATORIUM M. NUYTINCK, ANABIOTEC, OHMX.bio, Ziphius, MENTANA DX
since 2012
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Noorwegenstraat 4
9940 Evergem
Legeweg 176
8200 Brugge
Active since 14 November 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 10 companies are registered at this address.
All companies at this address →LABORATORIUM M. NUYTINCK same network
€ 24.5 million revenue · 2025
POST VERBA VERBERA same network
€ 4.5 million revenue · 2025
ANABIOTEC same network
€ 9 million gross margin · 2025
Group Nuytinck
OHMX.bio same network
€ 1.7 million gross margin · 2025
+5 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
LEVEL27-AS * Please direct all complaints to [email protected] *, BE
Website info
Features
Security
Network
Details
- Company number
- 0451.023.967
- VAT number
- BE 0451.023.967
- Registered office
- Noorwegenstraat 4, 9940 Evergem
- Names & denominations
- LABO VOOR KLINISCHE BIOLOGIE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 30 September 1993
- Peppol
- Active · Active since 5 Dec 2025
- Contact
- nuytinck.be 092536030
- Activities · NACE
Activiteiten van medische beeldvorming en medische laboratoria
Medische laboratoria
Activiteiten van medische laboratoria